What is Directo?
Founded in 2018, Directo operates as a business-to-business e-commerce platform specifically tailored for the pharmacy industry. Its marketplace model aims to streamline procurement and sales processes for pharmacies, connecting them with suppliers and facilitating transactions. The company's focus on the intersection of healthcare and digital commerce positions it within a rapidly evolving market, driven by the increasing demand for efficient and accessible pharmaceutical supply chains. Directo's strategic positioning in Melbourne, Australia, provides a strong base for its operations and future growth.
How much funding has Directo raised?
Directo has raised a total of $4.3M across 2 funding rounds:
Angel/Seed
$2.3M
Share Placement
$2M
Angel/Seed (2022): $2.3M with participation from Investible
Share Placement (2024): $2M, investors not publicly disclosed
Key Investors in Directo
Investible
Investible is an early-stage venture capital firm that typically invests in technology and innovation-driven companies. Their participation suggests a belief in Directo's disruptive potential within the pharmacy e-commerce sector.
What's next for Directo?
The recent major strategic investment signals a pivotal moment for Directo, likely enabling the company to accelerate its growth trajectory. This capital infusion is expected to fuel product development, enhance its marketplace capabilities, and expand its operational reach. Directo may focus on onboarding more suppliers and pharmacy clients, further solidifying its market position. The company's enterprise-level funding context suggests a move towards scaling operations, potentially exploring new geographic markets or diversifying its service offerings within the B2B pharmaceutical e-commerce space. Future developments will likely center on leveraging this investment to achieve greater market penetration and operational efficiency.
See full Directo company page
